Position in TNGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,481,817
New position
Shares Held
47,403
first reported quarter
Ownership
0.028%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#136
of 246 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Phoenix Financial Ltd. holds $16,652,062 across 6 Biotechnology names. TNGX ranks #3 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLGL |
Sol-Gel Technologies Ltd.
|
146,147 | $10,835,338 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,993 | $2,976,902 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
This page
|
47,403 | $1,481,817 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,109 | $691,505 | |
| 5 | MDWD |
MediWound Ltd.
|
39,000 | $573,300 | |
| 6 | PLX |
Protalix BioTherapeutics, Inc.
|
40,000 | $93,200 |
All Filings in TNGX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,481,817 | 47,403 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||